The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinico-molecular characteristics associated with outcomes in breast cancer patients treated with CDK4/6 inhibitors: Results from the AURORA Molecular Screening Initiative.
 
Elisa Agostinetto
Honoraria - AstraZeneca; Lilly; Sandoz
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo Europe GmbH; Genetic Spa; Novartis
 
Christos Sotiriou
Consulting or Advisory Role - Amgen; Amgen; Astellas Pharma; Astellas Pharma; CEPHEID; Merck; Puma Biotechnology; Seagen; Vertex
Speakers' Bureau - Eisai; Foundation Medicine; Genomic Health; Prime Oncology; Teva
Patents, Royalties, Other Intellectual Property - A companion diagnostic for CDK4/CDK6 inhibitory drugs based on CDK4 Phosphorylation. Which patient to be treated and how. PCT/EP2017/061780; Epigenetic portraits of human Breast Cancer, PCT/EP2012/050836, WO2012/098215
Travel, Accommodations, Expenses - Roche; Roche/Genentech; Roche/Genentech
 
Michail Ignatiadis
Consulting or Advisory Role - Seagen
Speakers' Bureau - Novartis
Research Funding - Inivata (Inst); Natera (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Patent entitled method for determining sensitivity to a CDK4/6 inh filed the 18 05 16 by Universite Libre de Bruxelles, Application No/Patent No 16170146.1-1403
Travel, Accommodations, Expenses - Gilead Sciences (Inst); Roche (Inst)
 
Thayane Antoniolli Crestani
Employment - Abbvie
Research Funding - Agendia (Inst); AstraZeneca (Inst); Biovica (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi/Aventis (Inst); SERVIER (Inst); Tesaro (Inst)
 
David Venet
No Relationships to Disclose
 
Svitlana Tyekucheva
No Relationships to Disclose
 
Alexandre Irrthum
Research Funding - AstraZeneca (Inst); Biovica (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi/Aventis (Inst); SERVIER (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - Agendia (Inst)
 
Jose A. Seoane
Patents, Royalties, Other Intellectual Property - Hold a patent application "Methods of Treatments Based Upon Anthracycline Responsiveness" from Stanford University; Hold a patent application "Methods of Treatments Based Upon Molecular Characterization of Breast" from Stanford University; Hold a patent: "Molecular block-matching method for gel image analysis" from Universidade da Coruna; Hold patent application "Systems and Methods to Identify Pancreatic Ductal Adenocarcinoma and Uses Thereof" from Stanford University
 
Martine J. Piccart-Gebhart
Consulting or Advisory Role - AstraZeneca; Camel-IDS; Frame Therapeutics; Gilead Sciences; Immunomedics; Immutep; Lilly; Menarini; MSD; NBE Therapeutics; Novartis; Pfizer; Roche/Genentech; Seagen; Seagen
Research Funding - AstraZeneca (Inst); Immunomedics/Gilead (Inst); Lilly (Inst); Menarini (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Roche/Genentech (Inst); Servier (Inst); Synthon (Inst)
Other Relationship - Oncolytics
 
David A. Cameron
Consulting or Advisory Role - Clarity Pharmaceuticals (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Novartis (Inst); Oncolytics (Inst); Pfizer (Inst); Prima BioMed (Inst); Puma Biotechnology (Inst); Research Triangle Institute RTI Health Solutions (Inst); Roche (Inst); Roche (Inst); Samsung Bioepis (Inst); Sanofi (Inst); Seagen (Inst); Synthon (Inst); Zymeworks (Inst); Zymeworks (Inst)
Research Funding - AstraZeneca (Inst); Novartis (Inst); Roche (Inst)
 
Susan Knox
Stock and Other Ownership Interests - Lilly
 
CRISTINA EMILIA ROTARU
Employment - ExeVIR; Takeda
Research Funding - Agendia (Inst); AstraZeneca (Inst); Biovica (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi/Aventis (Inst); SERVIER (Inst); Tesaro (Inst)
 
Dario Romagnoli
No Relationships to Disclose
 
Gabriele Zoppoli
Stock and Other Ownership Interests - Immunomica S.r.l.
Speakers' Bureau - Novartis
Research Funding - Thermo Fisher Scientific (Inst)
Patents, Royalties, Other Intellectual Property - European patent no. 102019000018989 concerning a "multi-domain method for prediction of one-year mortality in senior patients diagnosed with cancer"
Travel, Accommodations, Expenses - Novartis; Roche
 
Philippe Georges Aftimos
Honoraria - Gilead Sciences; Roche; Synthon
Consulting or Advisory Role - Amcure; Amgen; Boehringer Ingelheim; Deloitte; G1 Therapeutics; Gilead Sciences; Macrogenics; Menarini; Novartis; Novartis; Radius Health; Roche; Servier
Travel, Accommodations, Expenses - Amgen; MSD Oncology; Pfizer; Roche Belgium
 
Mafalda Oliveira
Honoraria - Eisai Europe; Gilead Sciences; MSD; Novartis; Pfizer; Roche; SeaGen
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; ITeos Therapeutics; Relay Therapeutics; Roche/Genentech; Seagen
Research Funding - AstraZeneca (Inst); Ayala Pharmaceuticals (Inst); Boehringer Ingelheim (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Roche/Genentech (Inst); Seagen (Inst); Zenith Epigenetics (Inst)
Travel, Accommodations, Expenses - AstraZeneca Spain; Eisai; Gilead Sciences; Pierre Fabre
 
Meredith M. Regan
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Debiopharm Group (Inst); Ipsen (Inst); Tersera; Tolmar
Research Funding - AstraZeneca (Inst); Bayer (Inst); bioTheranostics (Inst); Bristol-Myers Squibb (Inst); Debiopharm Group (Inst); Ipsen (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche (Inst); TerSera (Inst)
 
Luca Malorni
Honoraria - Novartis; Pfizer; Seagen
Consulting or Advisory Role - Novartis; Pfizer; Seagen
Research Funding - Novartis; Pfizer
Travel, Accommodations, Expenses - Gilead Sciences; Janssen; Roche
 
Matteo Benelli
Consulting or Advisory Role - Novartis
 
Florentine Hilbers
No Relationships to Disclose